124 related articles for article (PubMed ID: 21840180)
1. Potent antiviral activity of brequinar against the emerging Cantagalo virus in cell culture.
Schnellrath LC; Damaso CR
Int J Antimicrob Agents; 2011 Nov; 38(5):435-41. PubMed ID: 21840180
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of canine distemper virus replication by blocking pyrimidine nucleotide synthesis with A77 1726, the active metabolite of the anti-inflammatory drug leflunomide.
Li Y; Yi L; Cheng S; Wang Y; Wang J; Sun J; Zhang Q; Xu X
J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33416466
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of cidofovir against the emerging Cantagalo virus and the smallpox vaccine strain IOC.
Jesus DM; Moussatché N; Damaso CR
Int J Antimicrob Agents; 2009 Jan; 33(1):75-9. PubMed ID: 18804965
[TBL] [Abstract][Full Text] [Related]
4. Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesis.
Marschall M; Niemann I; Kosulin K; Bootz A; Wagner S; Dobner T; Herz T; Kramer B; Leban J; Vitt D; Stamminger T; Hutterer C; Strobl S
Antiviral Res; 2013 Dec; 100(3):640-8. PubMed ID: 24149002
[TBL] [Abstract][Full Text] [Related]
5. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
[TBL] [Abstract][Full Text] [Related]
6. Suppression of pyrimidine biosynthesis by targeting DHODH enzyme robustly inhibits rotavirus replication.
Chen S; Ding S; Yin Y; Xu L; Li P; Peppelenbosch MP; Pan Q; Wang W
Antiviral Res; 2019 Jul; 167():35-44. PubMed ID: 30974126
[TBL] [Abstract][Full Text] [Related]
7. D282, a non-nucleoside inhibitor of influenza virus infection that interferes with de novo pyrimidine biosynthesis.
Smee DF; Hurst BL; Day CW
Antivir Chem Chemother; 2012 Aug; 22(6):263-72. PubMed ID: 22516927
[TBL] [Abstract][Full Text] [Related]
8. Bleomycin differentially inhibits picornavirus, herpesvirus and poxvirus replication in a human carcinoma cell line.
Nørskov-Lauritsen N; Ebbesen P
In Vivo; 1993; 7(6A):481-5. PubMed ID: 7514894
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.
Luthra P; Naidoo J; Pietzsch CA; De S; Khadka S; Anantpadma M; Williams CG; Edwards MR; Davey RA; Bukreyev A; Ready JM; Basler CF
Antiviral Res; 2018 Oct; 158():288-302. PubMed ID: 30144461
[TBL] [Abstract][Full Text] [Related]
10. Control of lymphoproliferative and autoimmune disease in MRL-lpr/lpr mice by brequinar sodium: mechanisms of action.
Xu X; Gong H; Blinder L; Shen J; Williams JW; Chong AS
J Pharmacol Exp Ther; 1997 Nov; 283(2):869-75. PubMed ID: 9353408
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo mechanisms of action of the antiproliferative and immunosuppressive agent, brequinar sodium.
Xu X; Williams JW; Shen J; Gong H; Yin DP; Blinder L; Elder RT; Sankary H; Finnegan A; Chong AS
J Immunol; 1998 Jan; 160(2):846-53. PubMed ID: 9551920
[TBL] [Abstract][Full Text] [Related]
12. Restriction of vaccinia virus replication in CHO cells occurs at the stage of viral intermediate protein synthesis.
Ramsey-Ewing A; Moss B
Virology; 1995 Feb; 206(2):984-93. PubMed ID: 7856109
[TBL] [Abstract][Full Text] [Related]
13. Novobiocin inhibits vaccinia virus replication by blocking virus assembly.
Sekiguchi J; Shuman S
Virology; 1997 Aug; 235(1):129-37. PubMed ID: 9300044
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of brequinar against African swine fever virus infection in vitro.
Grigoryan R; Arabyan E; Izmailyan R; Karalyan Z; Jordão N; Ferreira F; Zakaryan H
Virus Res; 2022 Aug; 317():198826. PubMed ID: 35618075
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis.
Wang QY; Bushell S; Qing M; Xu HY; Bonavia A; Nunes S; Zhou J; Poh MK; Florez de Sessions P; Niyomrattanakit P; Dong H; Hoffmaster K; Goh A; Nilar S; Schul W; Jones S; Kramer L; Compton T; Shi PY
J Virol; 2011 Jul; 85(13):6548-56. PubMed ID: 21507975
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of brequinar analogue inhibitors of malaria parasite dihydroorotate dehydrogenase.
Boa AN; Canavan SP; Hirst PR; Ramsey C; Stead AM; McConkey GA
Bioorg Med Chem; 2005 Mar; 13(6):1945-67. PubMed ID: 15727850
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of vaccinia virus replication by peptide aptamers.
Saccucci L; Crance JM; Colas P; Bickle M; Garin D; Iseni F
Antiviral Res; 2009 Jun; 82(3):134-40. PubMed ID: 19428604
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human cytomegalovirus signaling and replication by the immunosuppressant FK778.
Evers DL; Wang X; Huong SM; Andreoni KA; Huang ES
Antiviral Res; 2005 Jan; 65(1):1-12. PubMed ID: 15652966
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of vaccinia virus replication by N-(phosphonoacetyl)-L-aspartate: differential effects on viral gene expression result from a reduced pyrimidine nucleotide pool.
Katsafanas GC; Grem JL; Blough HA; Moss B
Virology; 1997 Sep; 236(1):177-87. PubMed ID: 9299630
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of vaccinia virus replication by adenosine in BSC-40 cells: involvement of A(2) receptor-mediated PKA activation.
Leão-Ferreira LR; Paes-De-Carvalho R; De Mello FG; Moussatché N
Arch Virol; 2002 Jul; 147(7):1407-23. PubMed ID: 12111415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
